<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table I. Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.<footnote id="FOOT_2596">For various North American patient populations from literature reports. Different rates of elimination and consequent dosage requirements have been observed among other peoples.</footnote>
</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th colspan="2" valign="bottom">Population characteristics</th>
<th align="center">Total body clearance<footnote id="FOOT_2597">Clearance represents the volume of blood completely cleared of theophylline by the liver in one minute. Values listed were generally determined at serum theophylline concentrations less than 20 mcg/mL; clearance may decrease and half-life may increase at higher serum concentrations due to non-linear pharmacokinetics.</footnote>
<br/>mean (range)<footnote id="FOOT_2598">Reported range or estimated range (mean ± 2 SD) where actual range not reported.</footnote>
<br/>(mL/kg/min)</th>
<th align="center">Half-life<br/>mean (range)<footnoteref idref="FOOT_2598"></footnoteref>
<br/>(hr)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2"> <content stylecode="bold">
<content stylecode="underline">Age</content>
</content>
</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2"> Premature neonates</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2">   postnatal age 3–15 days</td>
<td>           0.29 (0.09–0.49)</td>
<td align="center"> 30 (17–43)</td>
</tr>
<tr>
<td colspan="2">   postnatal age 25–57 days</td>
<td>           0.64 (0.04–1.2)</td>
<td align="center"> 20 (9.4–30.6)</td>
</tr>
<tr>
<td colspan="2"> Term infants</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2">   postnatal age 1–2 days</td>
<td>           NR<footnote id="FOOT_2599">NR = not reported or not reported in a comparable format.</footnote>
</td>
<td align="center"> 25.7 (25–26.5)</td>
</tr>
<tr>
<td colspan="2">   postnatal age 3–30 weeks</td>
<td>           NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
<td align="center"> 11 (6–29)</td>
</tr>
<tr>
<td colspan="2"> Children</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2">   1–4 years</td>
<td>           1.7 (0.5–2.9)</td>
<td align="center"> 3.4 (1.2–5.6)</td>
</tr>
<tr>
<td colspan="2">   4–12 years</td>
<td>           1.6 (0.8–2.4)</td>
<td align="center"> NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
</tr>
<tr>
<td colspan="2">   13–15 years</td>
<td>           0.9 (0.48–1.3)</td>
<td align="center"> NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
</tr>
<tr>
<td colspan="2">   6–17 years</td>
<td>           1.4 (0.2–2.6)</td>
<td align="center"> 3.7 (1.5–5.9)</td>
</tr>
<tr>
<td colspan="2"> Adults (16–60 years)</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2">   Otherwise healthy non-smoking asthmatics</td>
<td valign="bottom">           0.65 (0.27–1.03)</td>
<td align="center" valign="bottom"> 8.7 (6.1–12.8)</td>
</tr>
<tr>
<td colspan="2"> Elderly (greater than 60 years)</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2">   non-smokers with normal cardiac, liver, and renal function</td>
<td valign="bottom">           0.41 (0.21–0.61)</td>
<td align="center" valign="bottom"> 9.8 (1.6–18)</td>
</tr>
<tr>
<td colspan="2"> <content stylecode="bold">
<content stylecode="underline">Concurrent illness or altered physiological state</content>
</content>
</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2"> Acute pulmonary edema</td>
<td>           0.33<footnote id="FOOT_2600">Median</footnote> (0.07–2.45)</td>
<td align="center"> 19<footnoteref idref="FOOT_2600"></footnoteref> (3.1–82)</td>
</tr>
<tr>
<td colspan="2"> COPD- greater than 60 years, stable</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2">   non-smoker greater than 1 year</td>
<td>           0.54 (0.44–0.64)</td>
<td align="center"> 11 (9.4–12.6)</td>
</tr>
<tr>
<td colspan="2"> COPD with cor pulmonale</td>
<td>           0.48 (0.08–0.88)</td>
<td align="center"> NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
</tr>
<tr>
<td colspan="2">   Cystic fibrosis (14–28 years)</td>
<td>           1.25 (0.31–2.2)</td>
<td align="center"> 6.0 (1.8–10.2)</td>
</tr>
<tr>
<td colspan="2"> Fever associated with-acute viral respiratory illness</td>
<td> </td>
<td align="center"> </td>
</tr>
<tr>
<td colspan="2"> (children 9–15 years)</td>
<td>           NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
<td align="center"> 7.0 (1.0–13)</td>
</tr>
<tr>
<td> Liver disease – </td>
<td> cirrhosis</td>
<td>           0.31<footnoteref idref="FOOT_2600"></footnoteref> (0.1–0.7)</td>
<td align="center"> 32<footnoteref idref="FOOT_2600"></footnoteref> (10–56)</td>
</tr>
<tr>
<td> </td>
<td> acute hepatitis</td>
<td>           0.35 (0.25–0.45)</td>
<td align="center"> 19.2 (16.6–21.8)</td>
</tr>
<tr>
<td> </td>
<td> cholestasis</td>
<td>           0.65 (0.25–1.45)</td>
<td align="center"> 14.4 (5.7–31.8)</td>
</tr>
<tr>
<td> Pregnancy – </td>
<td> 1st trimester</td>
<td>           NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
<td align="center"> 8.5 (3.1–13.9)</td>
</tr>
<tr>
<td> </td>
<td> 2nd trimester</td>
<td>           NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
<td align="center"> 8.8 (3.8–13.8)</td>
</tr>
<tr>
<td> </td>
<td> 3rd trimester</td>
<td>           NR<footnoteref idref="FOOT_2599"></footnoteref>
</td>
<td align="center"> 13.0 (8.4–17.6)</td>
</tr>
<tr>
<td colspan="2"> Sepsis with multi-organ failure</td>
<td>           0.47 (0.19–1.9)</td>
<td align="center"> 18.8 (6.3–24.1)</td>
</tr>
<tr>
<td> Thyroid disease – </td>
<td> hypothyroid</td>
<td>           0.38 (0.13–0.57)</td>
<td align="center"> 11.6 (8.2–25)</td>
</tr>
<tr>
<td> </td>
<td> hyperthyroid</td>
<td>           0.8 (0.68–0.97)</td>
<td align="center"> 4.5 (3.7–5.6)</td>
</tr>
</tbody>
</table>